title: Diagnosis of Recurrent and Metastatic Disease Using F-18 Fluorodeoxyglucose-Positron Emission Tomography.
abstract: One of the major strengths of F-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) in breast cancer imaging is in the evaluation of patients who have suspected loco-regional recurrence or distant metastasis. In general, FDG-PET is more sensitive than conventional imaging for the detection of recurrent disease. Because of its ability to more accurately stage patients who have advanced breast cancer, FDG-PET has a significant impact on choice of treatment and management in this patient group.
authors.affiliation: Department of Radiology, Puget Sound Veterans Administration Health Care System, 1660 South Columbian Way, Seattle, WA 98108-1597, USA.
authors.forename: William B
authors.initials: WB
authors.lastname: Eubank